CoChat

A randomized controlled trial of very early rehabilitation in speech after stroke

Open access

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index; none of the 13 sources its claims cite is checked for support yet.

Abstract

Rationale: The efficacy of rehabilitation therapy for aphasia caused by stroke is uncertain. Aims and hypothesis: The Very Early Rehabilitation of Speech (VERSE) trial aims to determine if intensive prescribed aphasia therapy (VERSE) is more effective and cost saving than non-prescribed, intensive (usual care-plus) and non-intensive usual care (UC) therapy when started within 15 days of stroke onset and continued daily over four weeks. We hypothesize that aphasia therapy when started very early after stroke and delivered daily could enhance recovery of communication compared with UC. Sample size estimates: A total of 246 participants (82 per arm) will provide 80% power to detect a 4.4% improvement on aphasia quotient between VERSE and UC plus at a significance level of α = 0.05. Setting: Acute-care hospitals and accompanying rehabilitation services throughout Australia, 2014–2017. Design: Three-arm, prospective, randomized, parallel group, open-label, blinded endpoint assessment (PROBE) trial. Participants: Acute stroke in previous 14 days and aphasia diagnosed by aphasia quotient (AQ) of the Western Aphasia Battery (WAB). Randomization: Computer-generated blocked randomization procedure stratified by aphasia severity according to Western Aphasia Battery, to one of three arms. Intervention: All participants receive UC—usual ward-based aphasia therapy. Arm 1: UC—no additional therapy; Arm 2: UC-plus usual ward-based therapy; Arm 3: VERSE therapy—a prescribed and structured aphasia therapy program. Arms 2 and 3 receive a total of 20 additional sessions (45–60 min, provided daily) of aphasia therapy. The additional intervention must be provided before day 50 post stroke. Study outcome measures: The aphasia quotient of Western Aphasia Battery at 12 weeks post stroke. Secondary outcomes include discourse measures, the Stroke and Aphasia Quality of Life Scale-39 and the Aphasia Depression Rating Scale at 12 and 26 weeks. Economic evaluation: Incremental cost-effectiveness ratios at 26 weeks will be reported. Discussion: This trial is designed to test whether the intensive and prescribed VERSE intervention is effective in promoting maximum recovery and preventing costly health complications in a vulnerable population of survivors of stroke. It will also provide novel, prospective, aphasia specific cost-effectiveness data to guide future policy development for this population.

Overview

CoChat Summary

TL;DR

This paper is a protocol for the VERSE randomized controlled trial, testing whether very early, intensive aphasia therapy after stroke improves communication and is cost-effective compared with usual care. It describes a three-arm, single-blinded multicentre trial with primary outcome at 12 weeks and follow-up at 26 weeks, but does not report trial results.

Key findings

  • The trial aims to enroll 246 participants to provide 80% power to detect the planned difference at α = 0.05, allowing for 5% non-adherence and 12% loss to analysis.
  • Since recruitment began, 81 patients had been enrolled from 11 hospitals.
  • The primary hypothesis is that early intensive aphasia therapy will produce at least a 20% greater score on the Aphasia Quotient (AQ) of the Western Aphasia Battery (WAB) at 12 weeks versus usual care.
  • A secondary hypothesis specifies a 4.4% greater AQ score for VERSE vs UC-Plus at 12 and 26 weeks, and cost-effectiveness is also hypothesized at 26 weeks.

Methods

  • Design: Three-armed, prospective, single-blinded, multicentre randomized controlled trial comparing Usual Care (UC), UC-Plus, and VERSE, with intention-to-treat analysis and a secondary per-protocol analysis.
  • Sample/data: Acute stroke patients >18 years with aphasia (AQ <93.7), medically stable, consented, and randomized within 14 days of stroke; participants were recruited across approximately 16 acute care hospitals and related rehabilitation services in Australia and New Zealand.
  • Main analysis: Primary analysis uses a generalized estimating equations model for AQ recovery at 12 weeks, adjusting for baseline AQ and NIHSS; secondary analyses compare groups at 12 and 26 weeks, including connected speech, SAQOL-39, and resource use/cost-effectiveness.

Limitations

  • The paper is a protocol, so it contains no outcome results; this is evident from the text and not a stated limitation.
  • The text states that the planned analysis assumes 5% non-adherence and 12% loss to analysis, indicating anticipated attrition/noncompliance, but it does not frame this as a limitation.
  • No explicit study limitations are stated in the provided text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/1747493016641116

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 10 Not checked · 6 Own results and interpretations

1 more claim

Create a free account to see all 16 claims and to verify the 13 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 5

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 12 references

Research works printed but not linked: 5

  1. Deloitte Access Economics, 2013, The economic impact of stroke in Australia
  2. Godecke E, 2013, Semin Speech Lang, 34, 239
  3. Brady MC, 2012, Cochrane Database Syst Rev, 5, CD000425
  4. Enderby PM, 1987, The Frenchay aphasia screening test
  5. Kaplan EF, 1983, Boston naming test. Experimental Edition

Cited by

See all 37

Metadata

Authors
Godecke, E., Armstrong, E. A., Rai, T., Middleton, S., Ciccone, N., Whitworth, A., Rose, M., Holland, A., Ellery, F., Hankey, G. J., Cadilhac, D. A., & Bernhardt, J.
Affiliations
  • Edith Cowan University (AU)
  • University of Technology Sydney (AU)
  • Australian Catholic University (AU)
  • Curtin University (AU)
  • La Trobe University (AU)
  • University of Arizona (US)
  • The University of Melbourne (AU)
  • The University of Western Australia (AU)
  • Monash University (AU)
Corresponding author
Godecke, Erin
Venue
International Journal of Stroke
Published
2016-05-05
Volume
11
Issue
5
Pages
586-592
ISSN
  • 1747-4930 (ISSN-L)
  • 1747-4949
OpenAlex
W2398728837
Cited by
32
References
11
Citations by year
2025: 2 · 2024: 1 · 2023: 7 · 2022: 1 · 2021: 5 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 1
FWCI
1.70
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • International Journal of Stroke (publishedVersion)
  • PubMed (publishedVersion)
  • OPUS - Open Publications of UTS Scholars (University of Technology Sydney) (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Research Bank (Australian Catholic University) (submittedVersion)
  • Australasian Journal of Paramedicine (submittedVersion)
  • eSpace (Curtin University) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
Keywords
aphasia, stroke, aphasia rehabilitation, intensive speech therapy, aphasia quotient, Western Aphasia Battery, communication recovery, quality of life, cost-effectiveness, acute stroke rehabilitation
MeSH terms
Stroke Rehabilitation, Aphasia, Australia, Cost-Benefit Analysis, Humans, Language Tests, New Zealand, Speech, Speech Therapy, Single-Blind Method, Treatment Outcome, Patient Selection, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized controlled trial of very early rehabilitation in speech after stroke. https://app.cochat.ai/papers/10.1177/1747493016641116
The paper
Godecke, E., Armstrong, E. A., Rai, T., Middleton, S., Ciccone, N., Whitworth, A., Rose, M., Holland, A., Ellery, F., Hankey, G. J., Cadilhac, D. A., & Bernhardt, J. (2016). A randomized controlled trial of very early rehabilitation in speech after stroke. International Journal of Stroke. https://doi.org/10.1177/1747493016641116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.